These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 16732169)
1. Alemtuzumab (Campath-1H): a systematic review in organ transplantation. Morris PJ; Russell NK Transplantation; 2006 May; 81(10):1361-7. PubMed ID: 16732169 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of alemtuzumab in organ transplantation: current clinical status. Ciancio G; Burke GW; Warque ME; Miller J BioDrugs; 2006; 20(2):85-92. PubMed ID: 16626166 [TBL] [Abstract][Full Text] [Related]
3. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Magliocca JF; Knechtle SJ Transpl Int; 2006 Sep; 19(9):705-14. PubMed ID: 16918530 [TBL] [Abstract][Full Text] [Related]
4. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation. Weissenbacher A; Boesmueller C; Brandacher G; Oellinger R; Pratschke J; Schneeberger S Immunotherapy; 2010 Nov; 2(6):783-90. PubMed ID: 21091110 [TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326 [TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab induction in deceased donor kidney transplantation. Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271 [TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab induction in deceased donor kidney transplantation. Huang E; Cho YW; Hayashi R; Bunnapradist S Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833 [TBL] [Abstract][Full Text] [Related]
10. Use of alemtuzumab (Campath-1H) as induction therapy in pediatric kidney transplantation. Ona ET; Danguilan RA; Africa J; Cabanayan-Casasola CB; Antonio ZL; Gutierrez-Marbella MA; dela Cruz R; Bumanglag N; Espedilla ME Transplant Proc; 2008 Sep; 40(7):2226-9. PubMed ID: 18790199 [TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use. Das B; Shoemaker L; Recto M; Austin E; Dowling R J Heart Lung Transplant; 2008 Feb; 27(2):242-4. PubMed ID: 18267235 [TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Gruessner RW; Kandaswamy R; Humar A; Gruessner AC; Sutherland DE Transplantation; 2005 May; 79(9):1184-9. PubMed ID: 15880067 [TBL] [Abstract][Full Text] [Related]
13. Campath-1H in renal transplantation: The University of Wisconsin experience. Knechtle SJ; Fernandez LA; Pirsch JD; Becker BN; Chin LT; Becker YT; Odorico JS; D'alessandro AM; Sollinger HW Surgery; 2004 Oct; 136(4):754-60. PubMed ID: 15467659 [TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients. Kirsch BM; Haidinger M; Zeyda M; Böhmig GA; Tombinsky J; Mühlbacher F; Watschinger B; Hörl WH; Säemann MD Transpl Immunol; 2006 Nov; 16(3-4):254-7. PubMed ID: 17138063 [TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab induction in kidney transplantation. Huang E; Cho YW; Shah T; Peng A; Hayashi R; Bunnapradist S Clin Transpl; 2005; ():343-54. PubMed ID: 17424750 [TBL] [Abstract][Full Text] [Related]
17. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression. Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990 [TBL] [Abstract][Full Text] [Related]
18. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up. Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200 [TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Morgan RD; O'Callaghan JM; Knight SR; Morris PJ Transplantation; 2012 Jun; 93(12):1179-88. PubMed ID: 22660659 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]